Jane Street
LIMN

Jane Street’s Liminatus Pharma LIMN Stock Holding History

Jane Street’s Portfolio LIMN Stock Details LIMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3K Buy
+71,318
New +$38K ﹤0.01% 11284
2025
Q4 		– Sell
-39,635
Closed -$66.2K – 12853
2025
Q3 		$66.2K Buy
+39,635
New +$171K ﹤0.01% 10268

Other funds holding LIMN

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's LIMN Position: Q1 2026 in Review

Jane Street opened a new position in Liminatus Pharma (LIMN) in Q1 2026: 71,318 shares worth $12.3K. The stake represents ﹤0.01% of the portfolio and ranks #11284 among its holdings. This is a return to the name: Jane Street previously reported a position in LIMN as recently as Q3 2025.

Jane Street first reported a position in LIMN in Q3 2025 and has held it in 2 quarters since. The position peaked at $66.2K in Q3 2025. 15 funds tracked by Wall St. Rank hold LIMN as of Q1 2026.

  • Jane Street held 71,318 shares of Liminatus Pharma worth $12.3K as of Q1 2026.
  • Liminatus Pharma was a new Jane Street position in Q1 2026.
  • Liminatus Pharma made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11284 holding.
  • Jane Street first reported a position in Liminatus Pharma in Q3 2025 and has held it in 2 quarters since.
  • Jane Street's Liminatus Pharma position peaked at $66.2K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Liminatus Pharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.